JOHNSON & JOHNSON (1JNJ.MI) Fundamental Analysis & Valuation
BIT:1JNJ • US4781601046
Current stock price
201.7 EUR
-2.55 (-1.25%)
Last:
This 1JNJ.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1JNJ.MI Profitability Analysis
1.1 Basic Checks
- In the past year 1JNJ was profitable.
- 1JNJ had a positive operating cash flow in the past year.
- 1JNJ had positive earnings in each of the past 5 years.
- 1JNJ had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- 1JNJ has a Return On Assets of 13.46%. This is amongst the best in the industry. 1JNJ outperforms 88.24% of its industry peers.
- The Return On Equity of 1JNJ (32.87%) is better than 80.39% of its industry peers.
- 1JNJ's Return On Invested Capital of 14.37% is fine compared to the rest of the industry. 1JNJ outperforms 74.51% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1JNJ is above the industry average of 13.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.46% | ||
| ROE | 32.87% | ||
| ROIC | 14.37% |
ROA(3y)14.08%
ROA(5y)12.66%
ROE(3y)34.55%
ROE(5y)31.04%
ROIC(3y)16.34%
ROIC(5y)15%
1.3 Margins
- The Profit Margin of 1JNJ (28.46%) is better than 92.16% of its industry peers.
- 1JNJ's Profit Margin has improved in the last couple of years.
- The Operating Margin of 1JNJ (27.78%) is better than 72.55% of its industry peers.
- In the last couple of years the Operating Margin of 1JNJ has grown nicely.
- With a Gross Margin value of 67.92%, 1JNJ perfoms like the industry average, outperforming 45.10% of the companies in the same industry.
- 1JNJ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.78% | ||
| PM (TTM) | 28.46% | ||
| GM | 67.92% |
OM growth 3Y6.15%
OM growth 5Y6.99%
PM growth 3Y8.26%
PM growth 5Y9.82%
GM growth 3Y-0.67%
GM growth 5Y0.65%
2. 1JNJ.MI Health Analysis
2.1 Basic Checks
- 1JNJ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for 1JNJ remains at a similar level compared to 1 year ago.
- 1JNJ has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, 1JNJ has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 5.00 indicates that 1JNJ is not in any danger for bankruptcy at the moment.
- 1JNJ has a better Altman-Z score (5.00) than 80.39% of its industry peers.
- The Debt to FCF ratio of 1JNJ is 2.43, which is a good value as it means it would take 1JNJ, 2.43 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of 1JNJ (2.43) is better than 70.59% of its industry peers.
- 1JNJ has a Debt/Equity ratio of 0.56. This is a neutral value indicating 1JNJ is somewhat dependend on debt financing.
- The Debt to Equity ratio of 1JNJ (0.56) is comparable to the rest of the industry.
- Even though the debt/equity ratio score it not favorable for 1JNJ, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.43 | ||
| Altman-Z | 5 |
ROIC/WACC1.51
WACC9.53%
2.3 Liquidity
- A Current Ratio of 1.03 indicates that 1JNJ should not have too much problems paying its short term obligations.
- 1JNJ has a Current ratio of 1.03. This is in the lower half of the industry: 1JNJ underperforms 70.59% of its industry peers.
- A Quick Ratio of 0.77 indicates that 1JNJ may have some problems paying its short term obligations.
- The Quick ratio of 1JNJ (0.77) is worse than 72.55% of its industry peers.
- 1JNJ does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.77 |
3. 1JNJ.MI Growth Analysis
3.1 Past
- 1JNJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.11%, which is quite good.
- 1JNJ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.11% yearly.
- The Revenue has been growing slightly by 6.05% in the past year.
- The Revenue has been growing slightly by 2.67% on average over the past years.
EPS 1Y (TTM)8.11%
EPS 3Y2.06%
EPS 5Y6.11%
EPS Q2Q%20.59%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y5.6%
Revenue growth 5Y2.67%
Sales Q2Q%9.08%
3.2 Future
- Based on estimates for the next years, 1JNJ will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.75% on average per year.
- 1JNJ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y7.91%
EPS Next 2Y8.38%
EPS Next 3Y8.73%
EPS Next 5Y8.75%
Revenue Next Year7.24%
Revenue Next 2Y6.55%
Revenue Next 3Y6.35%
Revenue Next 5Y6.02%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. 1JNJ.MI Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 21.83, 1JNJ is valued on the expensive side.
- 1JNJ's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.18, 1JNJ is valued at the same level.
- With a Price/Forward Earnings ratio of 20.22, 1JNJ is valued on the expensive side.
- 1JNJ's Price/Forward Earnings ratio is in line with the industry average.
- 1JNJ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.96.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.83 | ||
| Fwd PE | 20.22 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1JNJ.
- Based on the Price/Free Cash Flow ratio, 1JNJ is valued a bit more expensive than 60.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.82 | ||
| EV/EBITDA | 17.17 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- 1JNJ has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.76
PEG (5Y)3.57
EPS Next 2Y8.38%
EPS Next 3Y8.73%
5. 1JNJ.MI Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.15%, 1JNJ has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.95, 1JNJ pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, 1JNJ has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.15% |
5.2 History
- The dividend of 1JNJ is nicely growing with an annual growth rate of 7.68%!
Dividend Growth(5Y)7.68%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1JNJ pays out 46.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of 1JNJ is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP46.19%
EPS Next 2Y8.38%
EPS Next 3Y8.73%
1JNJ.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1JNJ (4/13/2026, 7:00:00 PM)
201.7
-2.55 (-1.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-21 2026-01-21/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners75.61%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap485.82B
Revenue(TTM)94.19B
Net Income(TTM)26.80B
Analysts76.25
Price Target207.16 (2.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.15% |
Yearly Dividend4.39
Dividend Growth(5Y)7.68%
DP46.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-0.13%
Max EPS beat(2)0.55%
EPS beat(4)3
Avg EPS beat(4)2.17%
Min EPS beat(4)-0.13%
Max EPS beat(4)5.96%
EPS beat(8)7
Avg EPS beat(8)2.84%
EPS beat(12)10
Avg EPS beat(12)3.23%
EPS beat(16)14
Avg EPS beat(16)3.09%
Revenue beat(2)2
Avg Revenue beat(2)0.35%
Min Revenue beat(2)0.03%
Max Revenue beat(2)0.67%
Revenue beat(4)4
Avg Revenue beat(4)1.04%
Min Revenue beat(4)0.03%
Max Revenue beat(4)2.92%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)8
Avg Revenue beat(12)-0.5%
Revenue beat(16)8
Avg Revenue beat(16)-4.44%
PT rev (1m)5.1%
PT rev (3m)12.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.08%
EPS NY rev (1m)0.06%
EPS NY rev (3m)-0.03%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)1.89%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.83 | ||
| Fwd PE | 20.22 | ||
| P/S | 6.03 | ||
| P/FCF | 28.82 | ||
| P/OCF | 23.14 | ||
| P/B | 6.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.17 |
EPS(TTM)9.24
EY4.58%
EPS(NY)9.97
Fwd EY4.95%
FCF(TTM)7
FCFY3.47%
OCF(TTM)8.72
OCFY4.32%
SpS33.47
BVpS28.98
TBVpS-6.26
PEG (NY)2.76
PEG (5Y)3.57
Graham Number77.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.46% | ||
| ROE | 32.87% | ||
| ROCE | 18.03% | ||
| ROIC | 14.37% | ||
| ROICexc | 16.57% | ||
| ROICexgc | 67.45% | ||
| OM | 27.78% | ||
| PM (TTM) | 28.46% | ||
| GM | 67.92% | ||
| FCFM | 20.91% |
ROA(3y)14.08%
ROA(5y)12.66%
ROE(3y)34.55%
ROE(5y)31.04%
ROIC(3y)16.34%
ROIC(5y)15%
ROICexc(3y)19.6%
ROICexc(5y)18.23%
ROICexgc(3y)74.51%
ROICexgc(5y)73.44%
ROCE(3y)20.24%
ROCE(5y)18.7%
ROICexgc growth 3Y3.9%
ROICexgc growth 5Y-2.01%
ROICexc growth 3Y8.52%
ROICexc growth 5Y5.62%
OM growth 3Y6.15%
OM growth 5Y6.99%
PM growth 3Y8.26%
PM growth 5Y9.82%
GM growth 3Y-0.67%
GM growth 5Y0.65%
F-Score4
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.43 | ||
| Debt/EBITDA | 1.36 | ||
| Cap/Depr | 64.4% | ||
| Cap/Sales | 5.13% | ||
| Interest Coverage | 6.81 | ||
| Cash Conversion | 72.86% | ||
| Profit Quality | 73.49% | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 5 |
F-Score4
WACC9.53%
ROIC/WACC1.51
Cap/Depr(3y)61.79%
Cap/Depr(5y)58.46%
Cap/Sales(3y)5.15%
Cap/Sales(5y)5.02%
Profit Quality(3y)88.82%
Profit Quality(5y)91.38%
High Growth Momentum
Growth
EPS 1Y (TTM)8.11%
EPS 3Y2.06%
EPS 5Y6.11%
EPS Q2Q%20.59%
EPS Next Y7.91%
EPS Next 2Y8.38%
EPS Next 3Y8.73%
EPS Next 5Y8.75%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y5.6%
Revenue growth 5Y2.67%
Sales Q2Q%9.08%
Revenue Next Year7.24%
Revenue Next 2Y6.55%
Revenue Next 3Y6.35%
Revenue Next 5Y6.02%
EBIT growth 1Y12.82%
EBIT growth 3Y12.1%
EBIT growth 5Y9.84%
EBIT Next Year23.27%
EBIT Next 3Y11.78%
EBIT Next 5Y8.55%
FCF growth 1Y-0.73%
FCF growth 3Y4.65%
FCF growth 5Y-0.49%
OCF growth 1Y1.09%
OCF growth 3Y4.99%
OCF growth 5Y0.83%
JOHNSON & JOHNSON / 1JNJ.MI Fundamental Analysis FAQ
What is the fundamental rating for 1JNJ stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1JNJ.MI.
What is the valuation status for 1JNJ stock?
ChartMill assigns a valuation rating of 2 / 10 to JOHNSON & JOHNSON (1JNJ.MI). This can be considered as Overvalued.
How profitable is JOHNSON & JOHNSON (1JNJ.MI) stock?
JOHNSON & JOHNSON (1JNJ.MI) has a profitability rating of 8 / 10.
What is the expected EPS growth for JOHNSON & JOHNSON (1JNJ.MI) stock?
The Earnings per Share (EPS) of JOHNSON & JOHNSON (1JNJ.MI) is expected to grow by 7.91% in the next year.
How sustainable is the dividend of JOHNSON & JOHNSON (1JNJ.MI) stock?
The dividend rating of JOHNSON & JOHNSON (1JNJ.MI) is 5 / 10 and the dividend payout ratio is 46.19%.